Saturday, 25 July 2026 (1300 – 1430 hrs)
Chairs:
Daniel TING, Singapore
WONG Tien Yin, Singapore
Leopold SCHMETTERER, Singapore
| Time | Presentation Topic | Speaker |
|---|---|---|
| 1300 – 1308 | AI for Glaucoma Care | Tobias ELZE, USA (Mass Eye & Ear) |
| 1308 – 1316 | AI Health Economics – Adoption and Return of Investment | Alvin LIU, USA (Wilmer Eye) |
| 1316 – 1324 | AI in Oculomics – What’s New in 2026? | Carol CHEUNG, Hong Kong SAR, China |
| 1324 – 1332 | AI in Clinical Trials | Namrata SAROJ, USA (Chief Business Officer, Ocular Therapeutix) |
| 1332 – 1340 | AI for Retina Care | Seung-Young YU, South Korea (Kyung Hee University) |
| 1340 – 1348 | AI in Eye: Crossing the Valley of Death | WONG Tien Yin, Singapore / China |
| 1348 – 1356 | AI Imaging for Ophthalmology: Opportunities and Challenges | Leopold SCHMETTERER, Singapore |
| 1356 – 1404 | Commercializing AI and Digital Devices for Ophthalmology: Pits and Pitfalls | Darius MOSHFEGHI, USA |
| 1404 – 1430 | Panel Discussion |